• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Exagen Inc (NQ: XGN )

    2.570 +0.140 (+5.76%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 49,135
    Open 2.390
    Bid (Size) 2.430 (3)
    Ask (Size) 2.590 (3)
    Prev. Close 2.430
    Today's Range 2.380 - 2.570
    52wk Range 1.300 - 3.710
    Shares Outstanding 16,126,784
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Exagen to Announce Third Quarter 2024 Results on November 12, 2024
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
    From Exagen Inc.
    Via GlobeNewswire

    Performance

    YTD
    +30.46%
    +30.46%
    1 Month
    -13.18%
    -13.18%
    3 Month
    +7.08%
    +7.08%
    6 Month
    +86.23%
    +86.23%
    1 Year
    +52.07%
    +52.07%

    More News

    Read More
    Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
    From Exagen Inc.
    Via GlobeNewswire
    Earnings Outlook For Exagen
    Via Benzinga
    Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29
    Via Investor Brand Network
    Market Mayhem Winners: What Stocks Are Up Today?
    Via InvestorPlace
    XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
    From Exagen Inc.
    Via GlobeNewswire
    Exagen to Announce Second Quarter 2024 Results on August 5, 2024
    From Exagen Inc.
    Via GlobeNewswire
    XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Announces Campaign for Lupus Awareness Month
    From Exagen Inc.
    Via GlobeNewswire
    Exagen to Announce First Quarter 2024 Results on May 13, 2024
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Announces Changes to the Board of Directors
    From Exagen Inc.
    Via GlobeNewswire
    XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
    From Exagen Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 18, 2024
    Via Benzinga
    Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
    From Exagen Inc.
    Via GlobeNewswire
    Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
    From Exagen Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.